CME Group (Nasdaq:CME) hit a new 52-week high Friday as it is currently trading at $74.53, above its previous 52-week high of $74.31 with 1.4 million shares traded as of 12:50 p.m. ET. Average volume has been 1.8 million shares over the past 30 days.
Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model. NEW YORK ( TheStreet) -- CME Group (Nasdaq: CME) hit a new 52-week high Friday as it is currently trading at $74.53, above its previous 52-week high of $74.31 with 1.4 million shares traded as of 12:50 p.m. ET. Average volume has been 1.8 million shares over the past 30 days. CME Group has a market cap of $24.13 billion and is part of the financial sector and financial services industry. Shares are up 42.6% year to date as of the close of trading on Thursday. CME Group Inc. operates the CME, CBOT, NYMEX COMEX, and KCBT futures exchanges worldwide. It operates CBOT exchange, a marketplace for trading agricultural and the U.S. The company has a P/E ratio of 27.7, above the S&P 500 P/E ratio of 17.7.
EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
TheStreet Ratings rates CME Group as a buy. The company's strengths can be seen in multiple areas, such as its expanding profit margins, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. You can view the full CME Group Ratings Report. See all 52-week high stocks or get investment ideas from our investment research center. 3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more..